Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
Susan Zolla‐Pazner, Raymond A Alvarez, Xiang‐Peng Kong, et al.
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 309-317
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 843-854.e12
Open Access | Times Cited: 382
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
Bin Su, Stefania Dispinseri, Valeria Iannone, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Xiaoying Shen, Bette Korber, Rachel L. Spreng, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 133-133
Open Access
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin‐Proulx, Maria Montero, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 9, pp. e1008764-e1008764
Open Access | Times Cited: 40
HIV vaccine delayed boosting increases Env variable region 2–specific antibody effector functions
David Easterhoff, Justin Pollara, Kan Luo, et al.
JCI Insight (2020) Vol. 5, Iss. 2
Open Access | Times Cited: 26
Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 21
Cryo-EM structures of prefusion SIV envelope trimer
Jason Gorman, Chunyan Wang, Rosemarie D. Mason, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 11, pp. 1080-1091
Open Access | Times Cited: 13
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+T cells through Integrin α4β7and promotes cellular activation and infection
Lívia R. Góes, Alia Sajani, Aida Sivro, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 51, pp. 32566-32573
Open Access | Times Cited: 20
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response
LaTonya D. Williams, Xiaoying Shen, Sheetal Sawant, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011359-e1011359
Open Access | Times Cited: 5
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
Ralf Duerr, Miroslaw K. Górny
Vaccines (2019) Vol. 7, Iss. 3, pp. 82-82
Open Access | Times Cited: 16
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
Svenja Weiß, Vincenza Itri, Ruimin Pan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
Avi Kenny, Janine van Duijn, One Dintwe, et al.
EBioMedicine (2024) Vol. 108, pp. 105320-105320
Closed Access | Times Cited: 1
P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion
Alexandra Y. Soare, Hagerah S. Malik, Natasha D. Durham, et al.
Journal of Virology (2019) Vol. 94, Iss. 6
Open Access | Times Cited: 12
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
Anusmita Sahoo, Andrew Jones, Narayanaiah Cheedarla, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 7
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
Anusmita Sahoo, Edgar A. Hodge, Celia C. LaBranche, et al.
Cell Reports (2022) Vol. 38, Iss. 9, pp. 110436-110436
Open Access | Times Cited: 6
Revisiting the Correlate of Reduced HIV Infection Risk in the Rv144 Vaccine Trial
Susan Zolla‐Pazner, Peter B. Gilbert
Journal of Virology (2019) Vol. 93, Iss. 17
Open Access | Times Cited: 9
Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers
Zhi Yang, Kim-Marie A. Dam, Jonathan M. Gershoni, et al.
Journal of Virology (2022) Vol. 96, Iss. 24
Open Access | Times Cited: 5
Impact of the expression system on the immune responses to self-assembling protein nanoparticles (SAPNs) displaying HIV-1 V1V2 loop
Christopher P. Karch, Dominic Paquin‐Proulx, Michael A. Eller, et al.
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 29, pp. 102255-102255
Open Access | Times Cited: 7
Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques
Santhi Devasundaram, Margherita Rosati, Antonio Valentin, et al.
Journal of Virology (2020) Vol. 95, Iss. 2
Open Access | Times Cited: 7
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251
Jeffy George, Asisa Volz, Olusegun O. Onabajo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers
Agricola Joachim, Frank Msafiri, Sayali Onkar, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 681-681
Open Access | Times Cited: 6
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, et al.
eLife (2024) Vol. 13
Open Access
A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1
Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, et al.
(2024)
Open Access
A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1
Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, et al.
(2024)
Open Access
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, et al.
eLife (2024) Vol. 13
Open Access
Page 1 - Next Page

Scroll to top